Sana Biotechnology Inc (SANA)

$4.76 +0.18 (3.93%)
Market Cap 1.22B
Revenue (ttm) 0.00
Net Income (ttm) -266.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,274,000
Avg Vol 4,135,540
Day's Range N/A - N/A
Shares Out 266.37M
Stochastic %K 39%
Beta 1.96
Analysts Strong Sell
Price Target $8.71

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline consist of UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
Sudhakar1990
Sudhakar1990 Jan. 21 at 8:08 PM
$SANA swing-swing
0 · Reply
BBraggHillBoys
BBraggHillBoys Jan. 21 at 4:37 PM
$SANA
0 · Reply
discountcroesus1
discountcroesus1 Jan. 21 at 2:49 PM
$SANA I'm very optimistic on SANA. But when I see its current market cap of $1.2B (and potential in the future may be x 4) I'm all the more optimistic on $BMEA potential future price growth. Biomea may be the gem that will disrupt the entire DIABETE (and obesity) market
1 · Reply
BriOnH
BriOnH Jan. 20 at 10:11 PM
$SANA "Aspect has acquired rights to stem cell-derived islet cell and hypoimmune cell engineering technologies from Novo Nordisk and will lead development, manufacturing and commercialisation. Novo Nordisk will have defined rights to expand its role in later-stage development and commercialisation. " https://aspectbiosystems.com/news-resources/aspect-biosystems-novo-nordisk-enter-new-phase-of-partnership-to-develop-curative-medicines-for-diabetes
1 · Reply
BriOnH
BriOnH Jan. 20 at 9:33 PM
$SANA Helps to open in a private browser window to circumvent access to read if needed: https://seekingalpha.com/article/4860889-sana-biotechnology-stock-promising-t1d-science-but-wait-for-dips
0 · Reply
BBraggHillBoys
BBraggHillBoys Jan. 20 at 6:33 PM
$SANA green in a red sea
0 · Reply
LoveRetailFroth
LoveRetailFroth Jan. 20 at 3:58 PM
$AMLX Good Morning ☕️ M&A full swing. $30 $40 …. $SANA $IMRX $RXRX
0 · Reply
sellthetop
sellthetop Jan. 19 at 3:25 PM
$SANA great video. But the interviewer was clueless about the most important part...is there any reason to buy the stock?? Why not just wait 12 months?
2 · Reply
BriOnH
BriOnH Jan. 18 at 6:04 PM
$SANA There is important information about 1/3 of the way through this vid about vrtx (assumption of) scaling problems. For full transparency I also own shares of ELDN because there is a chance I will need a kidney transplant before Sana's HIP is applied to kidneys, and I pray I don't ever have to be on Tac. I do believe ELDN is only a stop gap measure til every transplant has HIP applied. Again though, this has good information of the industry right now for us Sana holders. https://www.tiktok.com/@crushingt1/video/7595731180683562270?_r=1&_t=ZS-938B4lpTQ37
1 · Reply
BBraggHillBoys
BBraggHillBoys Jan. 17 at 5:20 PM
$SANA if all goes well $15 in 18mos
0 · Reply
Latest News on SANA
Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

Jan 19, 2026, 7:40 AM EST - 2 days ago

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 3:26 PM EST - 7 days ago

Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:26 PM EST - 14 days ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 8, 2025, 9:00 AM EST - 6 weeks ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 3, 2025, 5:03 PM EST - 7 weeks ago

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 5:43 PM EST - 7 weeks ago

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 24, 2025, 4:05 PM EST - 2 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Oct 16, 2025, 5:09 PM EDT - 3 months ago

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Oct 16, 2025, 4:18 PM EDT - 3 months ago

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Sana Biotech Stock — The Next '100-Bagger'?

Oct 15, 2025, 12:15 PM EDT - 3 months ago

Sana Biotech Stock — The Next '100-Bagger'?

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 4:34 PM EDT - 4 months ago

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 1:42 AM EDT - 4 months ago

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 10:03 PM EDT - 5 months ago

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28, 2025, 8:00 AM EDT - 5 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 26, 2025, 4:05 PM EDT - 5 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 20, 2025, 4:05 PM EDT - 5 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Aug 8, 2025, 2:58 PM EDT - 5 months ago

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 5 months ago

Sana Biotechnology Announces Pricing of Public Offering

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 4:38 PM EDT - 6 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 6, 2025, 7:00 AM EDT - 6 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Aug 4, 2025, 11:35 AM EDT - 6 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 10:05 AM EDT - 7 months ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Two Biotech Stocks Poised For Big Moves On Monday

Jun 23, 2025, 7:39 AM EDT - 7 months ago

Two Biotech Stocks Poised For Big Moves On Monday

LCTX

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 9, 2025, 4:05 PM EDT - 8 months ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Sana Biotechnology to Present at June 2025 Investor Conferences

May 28, 2025, 4:05 PM EDT - 8 months ago

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

May 19, 2025, 3:10 PM EDT - 8 months ago

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

May 19, 2025, 11:57 AM EDT - 8 months ago

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

May 14, 2025, 2:50 PM EDT - 9 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 9 months ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

May 8, 2025, 5:45 AM EDT - 9 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Apr 19, 2025, 8:10 AM EDT - 9 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sudhakar1990
Sudhakar1990 Jan. 21 at 8:08 PM
$SANA swing-swing
0 · Reply
BBraggHillBoys
BBraggHillBoys Jan. 21 at 4:37 PM
$SANA
0 · Reply
discountcroesus1
discountcroesus1 Jan. 21 at 2:49 PM
$SANA I'm very optimistic on SANA. But when I see its current market cap of $1.2B (and potential in the future may be x 4) I'm all the more optimistic on $BMEA potential future price growth. Biomea may be the gem that will disrupt the entire DIABETE (and obesity) market
1 · Reply
BriOnH
BriOnH Jan. 20 at 10:11 PM
$SANA "Aspect has acquired rights to stem cell-derived islet cell and hypoimmune cell engineering technologies from Novo Nordisk and will lead development, manufacturing and commercialisation. Novo Nordisk will have defined rights to expand its role in later-stage development and commercialisation. " https://aspectbiosystems.com/news-resources/aspect-biosystems-novo-nordisk-enter-new-phase-of-partnership-to-develop-curative-medicines-for-diabetes
1 · Reply
BriOnH
BriOnH Jan. 20 at 9:33 PM
$SANA Helps to open in a private browser window to circumvent access to read if needed: https://seekingalpha.com/article/4860889-sana-biotechnology-stock-promising-t1d-science-but-wait-for-dips
0 · Reply
BBraggHillBoys
BBraggHillBoys Jan. 20 at 6:33 PM
$SANA green in a red sea
0 · Reply
LoveRetailFroth
LoveRetailFroth Jan. 20 at 3:58 PM
$AMLX Good Morning ☕️ M&A full swing. $30 $40 …. $SANA $IMRX $RXRX
0 · Reply
sellthetop
sellthetop Jan. 19 at 3:25 PM
$SANA great video. But the interviewer was clueless about the most important part...is there any reason to buy the stock?? Why not just wait 12 months?
2 · Reply
BriOnH
BriOnH Jan. 18 at 6:04 PM
$SANA There is important information about 1/3 of the way through this vid about vrtx (assumption of) scaling problems. For full transparency I also own shares of ELDN because there is a chance I will need a kidney transplant before Sana's HIP is applied to kidneys, and I pray I don't ever have to be on Tac. I do believe ELDN is only a stop gap measure til every transplant has HIP applied. Again though, this has good information of the industry right now for us Sana holders. https://www.tiktok.com/@crushingt1/video/7595731180683562270?_r=1&_t=ZS-938B4lpTQ37
1 · Reply
BBraggHillBoys
BBraggHillBoys Jan. 17 at 5:20 PM
$SANA if all goes well $15 in 18mos
0 · Reply
BriOnH
BriOnH Jan. 17 at 1:56 AM
$SANA another great video @JerryMalone32 found. I think it really provides clear color of where we are at, and need to go. https://www.biotechtv.com/post/sana-biotechnology-january-15-2026
1 · Reply
JerryMalone32
JerryMalone32 Jan. 17 at 12:21 AM
$SANA another video. Some good color in the 8 minute mark. https://x.com/ilovejan6th/status/2011618076123594918?s=46&t=CE0JIK-cKDS4ISvXFCm5JA
0 · Reply
hitmongreen
hitmongreen Jan. 16 at 11:40 PM
$SANA 🤞
0 · Reply
Sudhakar1990
Sudhakar1990 Jan. 16 at 5:09 PM
$SANA If it breaks through $4.85 today, hit $5 plus.
0 · Reply
alphadog10
alphadog10 Jan. 16 at 3:52 PM
$SANA These are all facts by the way. I suggest people do their research here
0 · Reply
alphadog10
alphadog10 Jan. 16 at 3:51 PM
$SANA You can tell Harr wanted his own manufacturing like lineage has but didnt have the money/capability to do it. NOT a good look 😂 it says you KNOW what is better because that was your initial intention but cash got in the way 😢😕 time for CDMO PLAN B. Obviously wasnt his first choice though meaning he knows whats superior. You want to control your own in house manufacturing for a variety of reasons but sana/Harr couldn't do it .
1 · Reply
alphadog10
alphadog10 Jan. 16 at 3:45 PM
$SANA If you dont believe me sana holders, do yourself a favor and plug both companies into any AI you want (data driven responses no emotion) plug in both companies fundamentals and see which one is in a MUCH better position for success. Do it. I dare you. 😂
0 · Reply
alphadog10
alphadog10 Jan. 16 at 3:32 PM
$SANA hahhaa they dont even have it in phase 1 yet . They already have 260 million shares outstanding no partnership either. They'll be sucking big pharma off to stay alive soon. Watch...
0 · Reply
alphadog10
alphadog10 Jan. 16 at 3:25 PM
$SANA is garbage. LCTX is the far superior cell therapy company. No manufacturing no big pharma partnership too many outstanding shares lineage is much further along and closer to revenues they've restored vision in the blind for gods sake and movement in paralyzed patients. Already has 2 programs with RMAT designation through FDA and the added kicker they partnered with the biggest hearing loss company in the world, Demant for auditory neuronal cells to restore hearing in the deaf. SANA HAS NONE OF THAT. If lineage proves they can scale their hypoimmune islet program sana is just a worthless cash burning machine with no revenues in sight for at least 8 years. Dont walk from sana, run! Do your DD on lineage and you'll see. If you can prove all of these FACTS wrong id love to hear it 🤭🤷‍♂️
1 · Reply
Robiel_17
Robiel_17 Jan. 15 at 10:49 PM
$SANA I’m dad to 3 years old boy with diabetic, man it’s really hard. All the slepless night, and the crying, “ dad I don’t want to, dad it’s hurt” I guesse I juste wondering if it’s going to be cure for diabetic if so how long will it take?
2 · Reply
albert_Stocktwits
albert_Stocktwits Jan. 15 at 5:47 PM
$SANA thinking about buying in. Who here are the best or most knowledgeable on this stock? Thanks in advance
2 · Reply
mirko_papuga
mirko_papuga Jan. 15 at 7:01 AM
$SANA Just getting caught-up.... incredible milestone today with the SEC 8-K filing of the 12 month outcome of UP451. Congratulations to everyone at Sana, all the investors and the T1D community.
0 · Reply